Clinical trial
Flecainide in Treating Patients With Chronic Neuropathic Pain
NCT00002996 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00002996 |
|---|---|
| Title | Flecainide in Treating Patients With Chronic Neuropathic Pain |
| Official title | Flecainide for the Treatment of Chronic Neuropathic Pain: A Phase II Trial |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | flecainide acetate |
| Enrollment | 20 |
| Start date | May 4, 1998 |
| Primary completion | Apr 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 15, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: